Chronic Hemodialysis Catheter Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Global Chronic Hemodialysis Catheter Market By Type (Cuffed Tunneled Catheter, Non-cuffed Tunneled Catheter, Non-tunneled Catheter), By Tip Design (Step-Tip, Split-Tip, Symmetrical-Tip, Self-centering Tip, Y-Tip), By Coating (Heparin-coated Catheters, Polyurethane Coating, Antibiotic Coating, Others), By End User (Hospitals, Specialty Clinics, Others), and By Region (North America, South America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030

Chronic Hemodialysis Catheter Market Overview

Global chronic hemodialysis catheter market reached US$ YYbillion in 2022 and is expected to reach US$ YY billion by 2030, growing with a CAGR of YY% during the forecast period 2023-2030.

The global chronic hemodialysis catheter market has witnessed significant growth and transformations over the years, with various factors influencing its dynamics. HDCs (hemodialysis catheters) are a crucial component of kidney replacement therapy. These catheters are only seen as a temporary solution before installing more permanent vascular access, like arteriovenous fistulas or grafts.

Government investments and research, particularly in developing economies, will continue to drive utilization of advanced technologies and boost the global chronic hemodialysis catheter market. The respective innovative devices includes the use of novel materials such as silicone or polyurethane for better treatment.

Chronic Hemodialysis Catheter Market Scope

For more details on this report - Request for Sample

Market Dynamics: Drivers

Growing acquisitions of hemodialysis catheters among key players

Developed economies have been witnessing rapid growth in betterment of their healthcare sectors, driven by high income levels, investments and infrastructure development. Several countries have experienced substantial demand for chronic hemodialysis catheter owing to its positive outcomes in research. Various acquisitions and product launches among key players will be a crucial factor driving the growth of the market. 

On June 8, 2023, a portfolio of dialysis catheter devices and the Biopsy Tract Sealant Technology, BioSentry from AngioDynamics, Inc. have been acquired by Merit Medical Systems, Inc., an internationally recognized manufacturer and distributor of healthcare technology, for a total cash valuation of $100 million.

According to International Journal of Clinical Practices 2022, the results of the study conducted by Wannan Medical College associated with Yijishan Hospital show that the average Tunneled Cuffed Catheters (TCC) survive longer than two years. Regardless of age, sex, or primary condition, we discovered that TCC is an effective option for patients with Maintenance Hemodialysis (MHD) with poor vascular status or short survival time, or as a bridge while waiting for an internal fistula to grow.

Furthermore, the rising utilization of novel technologies or devices for the management of dialysis. Rising awareness among people and increasing research for innovative device development will be a major factor driving the growth of the chronic hemodialysis catheters market.

Market Dynamics: Restraints

Complications associated with the catheter  

Poor clinical results may be caused in part by hemodialysis catheters that have been chronically tunneled. The main issues with hemodialysis catheters involve infection, central vein stenosis and blockage, and poor function brought on by thrombosis and fibrin sheath. Inadequate hemodialysis can result from thrombosis or fibrin sheath because they impair blood flow, especially by reducing inflow via the arterial lumen. 

Short-term difficulties can be caused by the procedure itself, such as the inexperience of the provider, the site of access, the placement technique, the severity of the patient's disease, and concomitant conditions. The long-term effects of HDC include mechanical dysfunction, thrombosis, central venous stenosis, and catheter-related bloodstream infection (CRBSI).

Chronic Hemodialysis Catheter Market Segment Analysis

The global chronic hemodialysis catheter market is segmented based on type, tip design, coating, end user and region.

Cuffed Tunneled Catheter segment holds approximately 41% of market share 

Prior to the development or maturity of a long-term dialysis availability, such as an arteriovenous fistula (AVF) and arteriovenous grafty (AVG), tunneled catheters are utilized to provide vascular access. They are also utilized by patients who have used every available entry point for long-term access to dialysis. To reduce catheter disintegration, vascular harm, and catheter-related problems, tunneled catheters are composed of flexible materials like silicone or polyurethane-polycarbonate copolymer. 

In general, polyurethane-polycarbonate copolymers are biocompatible. Tunneled cuffed catheters had been subsequently created, and the cuff's goal is to build a fibrous tissue that may act as a barrier preventing infection. Furthermore, by limiting displacement, the cuff and the related fibrous tissue may also offer a more stable access.

According to Indian Journal of Radiology and Imaging article 2023, tunneled lines are linked to greater long-term results, but the insertion procedure is more difficult and intrusive. In patients expected to need HD for longer than 2 to 3 weeks, cuffed TDCs are thus preferred over non-tunneled catheters, unless the situation is urgent and speedy access is required. The majority of qualified applicants for a TDC have a history of documented chronic kidney disease (CKD).

Chronic Hemodialysis Catheter Market Geographical Penetration

North America accounted for around 33% of market share in 2022

Due to the rising need for chronic hemodialysis catheter in healthcare, manufacturers in North America have chances of increasing their operations. There are many producers and suppliers in North America and owing to the quick economic growth of the region, industrial production has expanded, driving the demand for chronic hemodialysis catheter. 

Increasing expenditure on healthcare and rising research studies, advancement of technologies and different type of devices for management, and increase in pharmaceutical or medical device business establishment across the region are also contributing to the growth of chronic hemodialysis catheter market share of this region. The market in this area is growing as people become more aware of various novel innovative products such as tunneled catheters. The aforementioned elements further attest to North America's hegemonic position in the world.

North America continues to be a key player in the global chronic hemodialysis catheter market, with United States leading the way. Government initiatives promoting infrastructure development and investment, and a focus on rising advancements have fueled the demand for chronic hemodialysis catheter in the U.S. United States have been proactive in executing several initiatives or researches, stimulating chronic hemodialysis catheter demand.

COVID-19 Impact Analysis

The outbreak of the COVID-19 pandemic in late 2019 created unprecedented challenges for industries worldwide, including the global chronic hemodialysis catheter market. As countries grappled with lockdowns, supply chain disruptions and reduced economic activity, the pharmaceutical sector, with a significant consumer of various device designs, was significantly impacted. Several efforts all throughout the world were impacted by the pandemic's broad lockdowns and limitations that started in early 2020. 

Major medical device industries came to a standstill and shifted their attention towards the management of COVID-19, leading to a slump in demand for chronic hemodialysis catheter. Now several research studies have been initiated and companies have again started trial for their products safety and efficacy. Overall, the impact of the pandemic on the global chronic hemodialysis catheter market is expected to be relatively moderate, with the market continuing to grow steadily due to the ongoing need and research for antimicrobial coated, self-cenetered catheter and other programs for management of renal kidney disease.

Key Developments

• On August 21, 2023, the Arrow ErgoPack Comprehensive Kits with Hemodialysis plus Large Bore Catheters have been made available in the United States, according to Teleflex Incorporated, a top global manufacturer of medical technologies. The goal of this upgrade is to give clinicians more alternatives and streamline their insertion routine. With a selection of French diameters, lumens, and lengths, this extended kit configuration gives clinicians the option of using either Arrowg+ard Blue Hemodialysis and Large Bore lines.
• On April 14, 2021, the U.S. Food and Drug Administration (FDA) granted 510(k) approval to BD (Becton, Dickinson and business), a preeminent worldwide medical technology business, for the Pristine a long-term Hemodialysis Catheter, a brand-new hemodialysis catheter with a distinctive symmetric Y-Tip side-hole free distal lumen design.

Competitive Landscape

The major global players in the market include Teleflex Incorporated, Medtronic, BD, AngioDynamics, Medical Components, Inc., Merit Medical Systems, Fresenius Medical Care AG & Co. KGaA, Haolang Technology (Foshan) Limited Co., Ltd., SCW Medicath Ltd and Vygon.

Why Purchase the Report?

• To visualize the global chronic hemodialysis catheter market segmentation based on type, tip design, coating, end user and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development. 
• Excel data sheet with numerous data points of chronic hemodialysis catheter market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global chronic hemodialysis catheter market report would provide approximately 69 tables, 69 figures and 186 Pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies